Published through 2026-11-03 01:21 UTC · Automated cloud publishing.
OptikosPrime and Eyewa Launch Smartphone Refraction Trial in Middle East
Understand the event
Vision technology company OptikosPrime has announced a strategic partnership with Eyewa, a prominent omnichannel eyewear retailer based in the Middle East. The collaboration aims to develop and validate Argus, OptikosPrime's smartphone-based refraction technology, through a trial conducted within Eyewa's retail stores. This initiative represents a significant step toward integrating mobile diagnostic tools into traditional optical retail environments. By leveraging Eyewa's established physical presence and digital infrastructure, OptikosPrime seeks to test the efficacy and user acceptance of its proprietary technology in a real-world setting. The partnership underscores a growing trend in the vision care industry toward decentralized, accessible eye health solutions that utilize consumer-grade hardware. While specific details regarding the duration of the trial or the number of participating locations were not fully elaborated in the available reporting, the focus remains on validating the technical performance of the Argus system under commercial conditions. This development highlights the potential for smartphone-based diagnostics to complement or streamline existing refractive services offered by major regional retailers.
AI-generated from reporting · updated 23 days ago
Reporting timeline
Follow the reporting for different perspectives.
- EyeSmartOptikosPrime Partners with Eyewa to Trial Smartphone-Based Refraction Technology in Middle East Retail Stores
Vision technology company OptikosPrime announced a strategic partnership with Eyewa, a major Middle East omnichannel eyewear retailer, to develop and validate its Argus smartphone-based refraction technology. The trial aims to integrate objective refraction estimates (sphere, cylinder, axis) into Eyewa’s customer journey across GCC online and physical channels, targeting the prescription barrier that often causes digital purchase abandonment. Argus is described as being in development, distinct from OptikosPrime’s existing VisionCheck screening tool. The announcement did not specify timelines for commercial rollout, regulatory approvals, or clinical validation data for Argus. OptikosPrime positions the technology to support digital models in developed markets and basic vision care in underserved communities, while Eyewa’s Chief Optical Officer cited it as a solution to speed and simplicity hurdles.